Innocan Pharma Corp
F:IP40
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innocan Pharma Corp
F:IP40
|
IL |
|
Uber Technologies Inc
BMV:UBER
|
US |
|
A
|
Addnode Group AB (publ)
F:AR7
|
SE |
|
S
|
Service Corporation International
XMUN:SVC
|
US |
|
Bollore SE
F:BOP
|
FR |
Shareholder Yield
Current shareholder yield for IP40 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IP40 Price
Innocan Pharma Corp
| Average Annual Return | -6.97% |
| Standard Deviation of Annual Returns | 61.5% |
| Max Drawdown | -90% |
| Market Capitalization | 24.3m EUR |
| Shares Outstanding | 4 500 000 |
| Percentage of Shares Shorted |
N/A
|
IP40 Return Decomposition
Main factors of price return
Stock Splits
IP40's latest stock split occurred on Sep 5, 2025
The company executed a 1-for-65 stock split, meaning that for every 65 shares held, investors received 1 new share.
Before the split, IP40 traded at 0.112 per share. Afterward, the share price was about 7.28.
The adjusted shares began trading on Sep 5, 2025. This was the only stock split in IP40's history.